{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:47:15Z","timestamp":1773287235576,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010882","name":"TianJin Education Committee","doi-asserted-by":"publisher","award":["2018KJ045"],"award-info":[{"award-number":["2018KJ045"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["19JCZDJC32900"],"award-info":[{"award-number":["19JCZDJC32900"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["18JCQNJC80400"],"award-info":[{"award-number":["18JCQNJC80400"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742624"],"award-info":[{"award-number":["2023M742624"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["20YFZCSY00060"],"award-info":[{"award-number":["20YFZCSY00060"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2021QN001"],"award-info":[{"award-number":["TJWJ2021QN001"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2023XK003"],"award-info":[{"award-number":["TJWJ2023XK003"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["81900131,82000219"],"award-info":[{"award-number":["81900131,82000219"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["8210010129"],"award-info":[{"award-number":["8210010129"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111640","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T08:25:05Z","timestamp":1708331105000},"page":"111640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients"],"prefix":"10.1016","volume":"130","author":[{"given":"Zhaoyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111640_b0005","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1172\/JCI61188","article-title":"Molecular pathogenesis of multiple myeloma and its premalignant precursor","volume":"122","author":"Kuehl","year":"2012","journal-title":"Journal of Clinical Investigation."},{"issue":"12","key":"10.1016\/j.intimp.2024.111640_b0010","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"The Lancet. Oncology."},{"key":"10.1016\/j.intimp.2024.111640_b0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.exphem.2015.04.010","article-title":"Novel therapeutic strategies for multiple myeloma","volume":"43","author":"Mimura","year":"2015","journal-title":"Exp Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111640_b0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/ijms20051248","article-title":"The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma","volume":"20","author":"Rasche","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.111640_b0025","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2016-10-745059","article-title":"Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma","volume":"129","author":"Gupta","year":"2017","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2024.111640_b0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI129205","article-title":"Immunotherapy of multiple myeloma","volume":"130","author":"Minnie","year":"2020","journal-title":"J Clin Invest."},{"key":"10.1016\/j.intimp.2024.111640_b0035","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/bloodadvances.2021005198","article-title":"FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology","volume":"6","author":"Botta","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.intimp.2024.111640_b0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers (basel)."},{"key":"10.1016\/j.intimp.2024.111640_b0045","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-016-2135-z","article-title":"Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies","volume":"73","author":"Guillerey","year":"2016","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.intimp.2024.111640_b0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol Rev."},{"issue":"1","key":"10.1016\/j.intimp.2024.111640_b0055","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.bbmt.2019.09.015","article-title":"Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling","volume":"26","author":"Holstein","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2024.111640_b0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2017.12.774","article-title":"BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee","volume":"24","author":"Holstein","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.intimp.2024.111640_b0065","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.bbmt.2018.11.001","article-title":"Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling","volume":"25","author":"Holstein","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.intimp.2024.111640_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cyto.b.22024","article-title":"Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma","volume":"102","author":"Tian","year":"2022","journal-title":"Cytometry. Part b, Clinical Cytometry."},{"key":"10.1016\/j.intimp.2024.111640_b0075","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111640_b0080","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"The Lancet. Oncology."},{"key":"10.1016\/j.intimp.2024.111640_b0085","doi-asserted-by":"crossref","unstructured":"R. J. Pessoa de Magalhaes,M. B. Vidriales,B. Paiva,C. Fernandez-Gimenez,R. Garcia-Sanz,M. V. Mateos,N. C. Gutierrez,Q. Lecrevisse,J. F. Blanco,J. Hernandez,N. de las Heras,J. Martinez-Lopez,M. Roig,E. S. Costa,E. M. Ocio,M. Perez-Andres,A. Maiolino,M. Nucci,J. De La Rubia,J. J. Lahuerta,J. F. San-Miguel,A. Orfao,G. Spanish Myeloma,c. s. g. Grupo Castellano-Leones de Gammapatias Monoclonales, Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry, Haematologica. 98 (2013) 79.","DOI":"10.3324\/haematol.2012.067272"},{"key":"10.1016\/j.intimp.2024.111640_b0090","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"The New England Journal of Medicine."},{"key":"10.1016\/j.intimp.2024.111640_b0095","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2018-09-825331","article-title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","volume":"133","author":"Pawlyn","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2024.111640_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663748","article-title":"Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients","volume":"12","author":"Zhaoyun","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.111640_b0105","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1158\/1078-0432.CCR-14-1618","article-title":"Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma","volume":"21","author":"Fichtner","year":"2015","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.intimp.2024.111640_b0110","doi-asserted-by":"crossref","first-page":"E507","DOI":"10.1002\/ajh.24807","article-title":"The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma","volume":"92","author":"Ghosh","year":"2017","journal-title":"Am J Hematol."},{"key":"10.1016\/j.intimp.2024.111640_b0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ajh.25481","article-title":"Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy","volume":"94","author":"Tschautscher","year":"2019","journal-title":"Am J Hematol."},{"key":"10.1016\/j.intimp.2024.111640_b0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4149\/neo_2021_200814N861","article-title":"Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant","volume":"68","author":"Stork","year":"2021","journal-title":"Neoplasma."},{"key":"10.1016\/j.intimp.2024.111640_b0125","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/bloodadvances.2018018564","article-title":"A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis","volume":"2","author":"B\u00f8gsted","year":"2018","journal-title":"Blood Advances."},{"key":"10.1016\/j.intimp.2024.111640_b0130","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2016-03-705319","article-title":"Grupo Espanol de Mieloma\/Programa para el Estudio de la Terapeutica en Hemopatias Malignas Cooperative Study, Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients","volume":"127","author":"Paiva","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2024.111640_b0135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/10428190410001655157","article-title":"In multiple myeloma clonotypic CD38- \/CD19+ \/ CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes","volume":"45","author":"Rasmussen","year":"2004","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.intimp.2024.111640_b0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124698","article-title":"Definition of a multiple myeloma progenitor population in mice driven by enforced expression of XBP1s","volume":"4","author":"Kellner","year":"2019","journal-title":"JCI Insight."},{"key":"10.1016\/j.intimp.2024.111640_b0145","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/bloodadvances.2017005447","article-title":"Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT","volume":"1","author":"Ho","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2024.111640_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.leukres.2016.08.008","article-title":"Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of naive cells and memory subsets","volume":"49","author":"Pojero","year":"2016","journal-title":"Leuk Res."},{"key":"10.1016\/j.intimp.2024.111640_b0155","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ijc.34405","article-title":"Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenstrom macroglobulinemia","volume":"152","author":"Cholujova","year":"2023","journal-title":"Int J Cancer."},{"key":"10.1016\/j.intimp.2024.111640_b0160","article-title":"FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma","volume":"8","author":"Jia","year":"2021","journal-title":"Front Med (lausanne)."},{"issue":"7","key":"10.1016\/j.intimp.2024.111640_b0165","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/cancers13071704","article-title":"B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients","volume":"13","author":"Mendon\u00e7a de Pontes","year":"2021","journal-title":"Cancers."},{"key":"10.1016\/j.intimp.2024.111640_b0170","doi-asserted-by":"crossref","unstructured":"C. A.-O. Gran,J. Liwing,A. K. Wagner,A. Verhoek,A. Gezin,E. Alici,H. Nahi, Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma, Am J Hematol. 96(2021)23.","DOI":"10.1002\/ajh.25999"},{"key":"10.1016\/j.intimp.2024.111640_b0175","doi-asserted-by":"crossref","unstructured":"Y. A.-O. Cohen,A. Saranga,M. A.-O. Gatt,N. Lavi,C. A.-O. Ganzel,H. Magen,I. Avivi,T. Tadmor,C. Suriu,O. Jarchowsky Dolberg,A. Papushado,S. Trestman,R. Ram, Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study, Am J Hematol. 93(2018)810.","DOI":"10.1002\/ajh.25098"},{"key":"10.1016\/j.intimp.2024.111640_b0180","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hon.2354","article-title":"The effect of microenvironmental factors on the development of myeloma cells","volume":"35","author":"Mark","year":"2017","journal-title":"Hematol Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:19:09Z","timestamp":1761589149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"alternative-id":["S1567576924001589"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111640","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111640"}}